Observed elevations in tau levels in the brain, CSF, and plasma in Alzheimer's disease are most consistent with decreased tau catabolism or increased tau synthesis at the neuronal level. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.